Daily News Podcast

SGLT2s for heart failure first, diabetes second


 

For patients with systemic heart failure but without diabetes, oral SGLT2s are the focus of multiple ongoing phase 3 clinical trials. Also today, influenza activity hits a seasonal high, the U.S. Supreme Court halts a Louisiana abortion law from taking effect, and cilostazol plus aspirin or clopidogrel reduces the risk of recurrent stroke.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Rise in HCV linked to OxyContin reformulation
MDedge Rheumatology
Clown-tox, tattooed immunity, and cingulum-bundle comedy
MDedge Rheumatology
Different disease features found with family history of psoriasis versus PsA
MDedge Rheumatology
Novel plasma biomarkers for Alzheimer’s
MDedge Rheumatology
New findings raise questions about the role of ANAs in SLE
MDedge Rheumatology
Hearing drills into patient impact of ACA legal challenge
MDedge Rheumatology
500 Women in Medicine: Part I
MDedge Rheumatology
Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale
MDedge Rheumatology
In search of an ear
MDedge Rheumatology
Biologics curb coronary artery plaques in severe psoriasis
MDedge Rheumatology